Search

Paul V. Ward

Examiner (ID: 13921, Phone: (571)272-2909 , Office: P/1624 )

Most Active Art Unit
1624
Art Unit(s)
1624, 1623, 1622
Total Applications
2552
Issued Applications
1846
Pending Applications
195
Abandoned Applications
548

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18127925 [patent_doc_number] => 11554120 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-17 [patent_title] => 1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor [patent_app_type] => utility [patent_app_number] => 16/527802 [patent_app_country] => US [patent_app_date] => 2019-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 33223 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16527802 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/527802
1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor Jul 30, 2019 Issued
Array ( [id] => 15850455 [patent_doc_number] => 10640493 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-05 [patent_title] => Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer [patent_app_type] => utility [patent_app_number] => 16/526620 [patent_app_country] => US [patent_app_date] => 2019-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 46969 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16526620 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/526620
Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer Jul 29, 2019 Issued
Array ( [id] => 15524677 [patent_doc_number] => 20200054644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-20 [patent_title] => THERAPEUTIC COMPOUNDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/522550 [patent_app_country] => US [patent_app_date] => 2019-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51940 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16522550 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/522550
Therapeutic compounds and uses thereof Jul 24, 2019 Issued
Array ( [id] => 15147661 [patent_doc_number] => 20190352308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-21 [patent_title] => KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATIONS [patent_app_type] => utility [patent_app_number] => 16/522124 [patent_app_country] => US [patent_app_date] => 2019-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21950 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16522124 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/522124
KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATIONS Jul 24, 2019 Abandoned
Array ( [id] => 17111718 [patent_doc_number] => 20210292315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-23 [patent_title] => SELENIUM-CONTAINING ISOXAZOLAMINE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/261955 [patent_app_country] => US [patent_app_date] => 2019-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8584 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17261955 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/261955
SELENIUM-CONTAINING ISOXAZOLAMINE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF Jul 21, 2019 Abandoned
Array ( [id] => 15990315 [patent_doc_number] => 20200171028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-04 [patent_title] => METALLOENZYME INHIBITOR COMPOUNDS [patent_app_type] => utility [patent_app_number] => 16/518279 [patent_app_country] => US [patent_app_date] => 2019-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 102212 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16518279 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/518279
METALLOENZYME INHIBITOR COMPOUNDS Jul 21, 2019 Abandoned
Array ( [id] => 17526792 [patent_doc_number] => 11299463 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-04-12 [patent_title] => Process for the manufacture of pyrazoles or pyrimidones [patent_app_type] => utility [patent_app_number] => 16/517542 [patent_app_country] => US [patent_app_date] => 2019-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13910 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 291 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16517542 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/517542
Process for the manufacture of pyrazoles or pyrimidones Jul 19, 2019 Issued
Array ( [id] => 16925188 [patent_doc_number] => 11046649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-29 [patent_title] => Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase [patent_app_type] => utility [patent_app_number] => 16/514382 [patent_app_country] => US [patent_app_date] => 2019-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26740 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 372 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16514382 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/514382
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase Jul 16, 2019 Issued
Array ( [id] => 16862741 [patent_doc_number] => 11021470 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-01 [patent_title] => 2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof [patent_app_type] => utility [patent_app_number] => 16/514675 [patent_app_country] => US [patent_app_date] => 2019-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 37899 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 397 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16514675 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/514675
2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof Jul 16, 2019 Issued
Array ( [id] => 17067224 [patent_doc_number] => 20210269439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => PYRIDOPYRIMIDINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/257172 [patent_app_country] => US [patent_app_date] => 2019-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16736 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 264 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257172 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/257172
Pyridopyrimidine derivative, preparation method therefor and medical use thereof Jul 1, 2019 Issued
Array ( [id] => 20256089 [patent_doc_number] => 12428432 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-30 [patent_title] => Thienopyrimidine derivatives having stereo configurations and use thereof in medicine [patent_app_type] => utility [patent_app_number] => 17/624572 [patent_app_country] => US [patent_app_date] => 2019-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10716 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 277 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17624572 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/624572
Thienopyrimidine derivatives having stereo configurations and use thereof in medicine Jul 1, 2019 Issued
Array ( [id] => 16549715 [patent_doc_number] => 10882864 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-01-05 [patent_title] => Process for preparing BTK inhibitors [patent_app_type] => utility [patent_app_number] => 16/460889 [patent_app_country] => US [patent_app_date] => 2019-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 34491 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 212 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16460889 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/460889
Process for preparing BTK inhibitors Jul 1, 2019 Issued
Array ( [id] => 17065767 [patent_doc_number] => 20210267982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => FOLATE PREPARATIONS [patent_app_type] => utility [patent_app_number] => 17/256456 [patent_app_country] => US [patent_app_date] => 2019-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6156 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17256456 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/256456
Folate preparations Jun 30, 2019 Issued
Array ( [id] => 15323931 [patent_doc_number] => 20200002295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-02 [patent_title] => AMINOPYRAZINE DERIVATIVES AS PI3K-y INHIBITORS [patent_app_type] => utility [patent_app_number] => 16/458530 [patent_app_country] => US [patent_app_date] => 2019-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65127 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16458530 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/458530
Aminopyrazine derivatives as PI3K-g inhibitors Jun 30, 2019 Issued
Array ( [id] => 16832086 [patent_doc_number] => 11008326 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-05-18 [patent_title] => Synthesis of coelenterazine [patent_app_type] => utility [patent_app_number] => 16/457788 [patent_app_country] => US [patent_app_date] => 2019-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16881 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16457788 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/457788
Synthesis of coelenterazine Jun 27, 2019 Issued
Array ( [id] => 16832086 [patent_doc_number] => 11008326 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-05-18 [patent_title] => Synthesis of coelenterazine [patent_app_type] => utility [patent_app_number] => 16/457788 [patent_app_country] => US [patent_app_date] => 2019-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16881 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16457788 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/457788
Synthesis of coelenterazine Jun 27, 2019 Issued
Array ( [id] => 16832086 [patent_doc_number] => 11008326 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-05-18 [patent_title] => Synthesis of coelenterazine [patent_app_type] => utility [patent_app_number] => 16/457788 [patent_app_country] => US [patent_app_date] => 2019-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16881 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16457788 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/457788
Synthesis of coelenterazine Jun 27, 2019 Issued
Array ( [id] => 16832086 [patent_doc_number] => 11008326 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-05-18 [patent_title] => Synthesis of coelenterazine [patent_app_type] => utility [patent_app_number] => 16/457788 [patent_app_country] => US [patent_app_date] => 2019-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16881 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16457788 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/457788
Synthesis of coelenterazine Jun 27, 2019 Issued
Array ( [id] => 15023339 [patent_doc_number] => 20190322674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-24 [patent_title] => IMIDAZOPYRIDAZINE COMPOUNDS [patent_app_type] => utility [patent_app_number] => 16/455020 [patent_app_country] => US [patent_app_date] => 2019-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24180 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16455020 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/455020
Imidazopyridazine compounds Jun 26, 2019 Issued
Array ( [id] => 17981137 [patent_doc_number] => 20220347173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-03 [patent_title] => METHODS OF TREATING LIVER FIBROSIS USING CALPAIN INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/255168 [patent_app_country] => US [patent_app_date] => 2019-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47088 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255168 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/255168
METHODS OF TREATING LIVER FIBROSIS USING CALPAIN INHIBITORS Jun 26, 2019 Abandoned
Menu